Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited (BDMD) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bdmd · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Baird Medical Investment Holdings Limited (BDMD) measures how much investors pay for each dollar of the company's trailing earnings. BDMD's current PE ratio of N/A is calculated by dividing its stock price of $1.28 by its TTM earnings per share of -$0.94.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%7.7x
MedianQ3 · 75%15.6x
Max
At N/A, BDMD's current P/E is lower than in 0% of its annual fiscal year readings over the past 5 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Baird Medical Investment Holdings LimitedYou BDMD | $52M | N/A | — | -$0.94 |
 Biodesix, Inc. BDSX | $125M | N/A | — | -$4.67 |
 HeartBeam, Inc. BEAT | $28M | N/A | — | -$0.62 |
 Cytosorbents Corporation CTSO | $27M | N/A | — | -$0.13 |
 electroCore, Inc. ECOR | $80M | N/A | — | -$1.65 |
 FibroGen, Inc. FGEN | $37M | 0.19x | — | $45.38 |
 IceCure Medical Ltd ICCM | $8M | N/A | — | -$7.10 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.98 | — | |
2024-12-31 FY2024 | 15.60x | $0.49 | +102.5% | |
2023-12-31 FY2023 | 7.70x | $1.39 | +50.1% | |
2022-12-31 FY2022 | 5.13x | $2.00 | -15.4% | |
2021-12-31 FY2021 | 6.07x | $1.62 | -38.0% | |
2020-12-31 FY2020 | 9.79x | $0.99 | — | |
2019-12-31 FY2019 | — | $-1.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Baird Medical Investment Holdings Limited (BDMD) measures how much investors pay for each dollar of the company's trailing earnings. BDMD's current PE ratio of N/A is calculated by dividing its stock price of $1.28 by its TTM earnings per share of -$0.94.
Frequently asked questions
BDMD pe ratio · 6 questionsBDMD's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.28 and TTM EPS of -$0.94. Data sourced from Financial Modeling Prep via BDMD's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Baird Medical Investment Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09